GlassScriptPhysician profile
Jayashri V Ghate
NPI 1245224542
$9,821.21
in general payments reported to CMS, 2019-2025
39 companies · $2,415 in 2025
The $2,415 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,612 · 2020: $472 · 2021: $202 · 2022: $657 · 2023: $1,901 · 2024: $2,562 · 2025: $2,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,509 · Education: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,508.94 |
| Education | $369.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,287.58 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,043.52 | 2019-2025 | Ilumya, Blu-U |
| Genzyme Corporation | $739.98 | 2019-2025 | |
| Janssen Biotech, INC. | $680.68 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Regeneron Healthcare Solutions, INC. | $656.81 | 2019-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $480.47 | 2019-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $450.82 | 2019-2025 | Ebglyss, Olumiant, Taltz |
| Amgen INC. | $414.64 | 2019-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $365.09 | 2019-2025 | |
| Ucb, INC. | $352.40 | 2019-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $302.52 | 2023-2025 | Opzelura |
| Pfizer INC. | $287.05 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $274.37 | 2019-2024 | Arazlo, Cabtreo |
| E.R. Squibb & Sons, L.L.C. | $236.88 | 2023-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $148.60 | 2023-2025 | Zoryve |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayashri Ghate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.